United Therapeutics Corp

NMS: UTHR
Pharmaceuticals
Silver Spring MD
Title 1Chairman; Chief Executive Officer
Executive 1Dr. Martine A. Rothblatt, Ph.D., Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
2015 Revenue (US$ Millions)$1,466
2014 Revenue (US$ Millions)$1,289
Revenue Growth (%)13.76%
Net Income (US$ Millions)$652
Common Shares Outstanding (Millions)$46
Earnings Per Share (US$)$12.72
Price To Earnings Ratio13.31
Total Equity (US$ Millions)$1,600
Return On Equity (%)51.49%
Long Term Debt (US$ Millions)N/A
Debt To Equity Ratio (%)N/A
Market Capitalization (US$ Millions)$7,167
Total Assets (US$ Millions)$2,184
Current Assets (US$ Millions)$1,275
Inventories (US$ Millions)$81
Current Liabilities (US$ Millions)$441
Cost of Goods Sold (US$ Millions)$69
Asset Turnover0.67
Inventory Turnover0.93